Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,546.46
(
-0.52%
)
US TECH 100
23,303.20
(
-0.92%
)
Dow Jones
45,976.88
(
-0.50%
)
Brent Oil
99.69
(
2.99%
)
Bitcoin
70,245.00
(
-0.92%
)
News Focus
News Focus

Replies to post #78098 on Biotech Values

Replies to #78098 on Biotech Values
icon url

genisi

05/20/09 11:48 AM

#78209 RE: rkrw #78098

Should be more potent than Nexavar and dosed less frequently, but could also be more toxic. Btw, ONXX said at the Deutsche Bank Annual Health Care conference that the structure of F-sorafenib was claimed in its original patent.